National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018

Expert Consensus Document on the Management of Hyperkalaemia in Patients with Cardiovascular Disease Treated with Renin Angiotensin Aldosterone System Inhibitors: Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Chronic Kidney Disease in Adults: Assessment and Management

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

GUIDELINE 11: Use of Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers in CKD

Estimating Lifetime Benefits of Comprehensive Disease-Modifying Pharmacological Therapies in Patients with Heart Failure with Reduced Ejection Fraction: A Comparative Analysis of Three Randomised Controlled Trials

Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry

Factors Associated with Underuse of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction: An Analysis of 11 215 Patients from the Swedish Heart Failure Registry

Medical Therapy for Heart Failure with Reduced Ejection Fraction: The CHAMP-HF Registry

Association Between Enrolment in a Heart Failure Quality Registry and Subsequent Mortality—A Nationwide Cohort Study

Mineralocorticoid Receptor Antagonist Pattern of Use in Heart Failure with Reduced Ejection Fraction: Findings from BIOSTAT-CHF

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year Follow-up Outcomes and Differences Across Regions

Physicians' Adherence to Guideline-recommended Medications in Heart Failure with Reduced Ejection Fraction: Data from the QUALIFY Global Survey

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot)

Efficacy and Safety of Exercise Training in Patients with Chronic Heart Failure: HF-ACTION Randomized Controlled Trial.

Use of Aldosterone Antagonists in Heart Failure

Factors Identified as Precipitating Hospital Admissions for Heart Failure and Clinical Outcomes: Findings from OPTIMIZE-HF

Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings from IMPROVE HF

EuroHeart Failure Survey II (EHFS II): A Survey on Hospitalized Acute Heart Failure Patients: Description of Population

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure. Randomized Aldactone Evaluation Study Investigators

Balancing RAASi Therapy and Potassium: Understanding How it Works

Das Gleichgewicht zwischen RAASi-Therapie und Kalium: Die Wirkmechanismen

Beyond Anemia: Understanding the Significance and Treatment of Iron Deficiency

Don’t Be Fooled: It’s Iron Deficiency, Not Just Anemia

Examining Heart Failure Management: Can We Be Doing Better?

Iron Deficiency and Anemia: What’s the Difference?

Mechanismen bei Herzinsuffizienz: Die Auswirkungen von Eisenmangel

Management of Heart Failure: Time to Consider New Options?

Potassium Binders in Heart Failure: Who, When, and How

Potassium Management

Potassium Management in Patients at Risk for Hyperkalemia